Study results at 2 months suggest that LTRA was equivalent to an inhaled glucocorticoid as first-line controller therapy and to LABA as add-on therapy for diverse primary care patients.

Use of a leukotriene receptor antagonist (LTRA) for asthma management did not increase the risk of neuropsychiatric disease, based on data from more than 60,000 asthma patients.. Although LTRAs ...

"Combining certain treatments or adding an additional treatment can often help allergic rhinitis symptoms and improve quality of life," Jafari, who was not involved in the study, said in an email.